[1] KHORASANIZADEH M, YOUSEFIFARD M, ESKIAN M, et al. Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019:1-17.
[2] KUMAR H, ROPPER AE, LEE SH, et al. Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury. Mol Neurobiol. 2017;54(5):3578-3590.
[3] FAN B, WEI Z, YAO X, et al. Microenvironment Imbalance of Spinal Cord Injury. Cell Transplant. 2018;27(6):853-866.
[4] CHEN YX, ZULIYAER T, LIU B, et al. Sodium selenite promotes neurological function recovery after spinal cord injury by inhibiting ferroptosis. Neural Regen Res. 2022;17(12):2702-2709.
[5] 王臣健,陈春晓,徐涛,等. 阿魏酸钠对大鼠脊髓损伤中NLRP3炎性小体的影响及机制[J]. 中国脊柱脊髓杂志,2021,31(8):739-748.
[6] MCKENZIE BA, DIXIT VM, POWER C. Fiery Cell Death: Pyroptosis in the Central Nervous System. Trends Neurosci. 2020;43(1):55-73.
[7] 高书涛,荀传辉,盛伟斌. NLRP3炎症小体在创伤性脊髓损伤中作用的研究进展[J]. 中国脊柱脊髓杂志,2019,29(11):1042-1045.
[8] DE RIVERO VACCARI JP, LOTOCKI G, MARCILLO AE, et al. A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci. 2008;28(13):3404-3414.
[9] TRENDELENBURG G. Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways. J Cereb Blood Flow Metab. 2014;34(12):1857-1867.
[10] DISABATO DJ, QUAN N, GODBOUT JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139 Suppl 2:136-153.
[11] GAUDET AD, FONKEN LK. Glial Cells Shape Pathology and Repair After Spinal Cord Injury. Neurotherapeutics. 2018;15(3):554-577.
[12] ZHAO H, WANG X, LIU S, et al. Paeonol regulates NLRP3 inflammasomes and pyroptosis to alleviate spinal cord injury of rat. BMC Neurosci. 2022;23(1):16.
[13] VERMA SK, ARORA I, JAVED K, et al. Enhancement in the Neuroprotective Power of Riluzole Against Cerebral Ischemia Using a Brain Targeted Drug Delivery Vehicle. ACS Appl Mater Interfaces. 2016;8(30):19716-19723.
[14] XU S, WU Q, ZHANG W, et al. Riluzole Promotes Neurite Growth in Rats after Spinal Cord Injury through the GSK-3β/CRMP-2 Pathway. Biol Pharm Bull. 2022;45(5):569-575.
[15] XU J, HE J, HE H, et al. Comparison of RNAi NgR and NEP1-40 in Acting on Axonal Regeneration After Spinal Cord Injury in Rat Models. Mol Neurobiol. 2017;54(10):8321-8331.
[16] WHITE-SCHENK D, SHI R, LEARY JF. Nanomedicine strategies for treatment of secondary spinal cord injury. Int J Nanomedicine. 2015; 10:923-938.
[17] FAN B, WEI Z, FENG S. Progression in translational research on spinal cord injury based on microenvironment imbalance. Bone Res. 2022;10(1):35.
[18] WU J, ZHAO Z, SABIRZHANOV B, et al. Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways. J Neurosci. 2014;34(33):10989-11006.
[19] XU S, WANG J, ZHONG J, et al. CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling. Clin Transl Med. 2021;11(1):e269.
[20] AL MAMUN A, WU Y, MONALISA I, et al. Role of pyroptosis in spinal cord injury and its therapeutic implications. J Adv Res. 2021;28:97-109.
[21] LU F, LAN Z, XIN Z, et al. Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases. J Cell Physiol. 2020;235(4):3207-3221.
[22] JI X, SONG Z, HE J, et al. NIMA-related kinase 7 amplifies NLRP3 inflammasome pro-inflammatory signaling in microglia/macrophages and mice models of spinal cord injury. Exp Cell Res. 2021;398(2): 112418.
[23] FAVERO FM, VOOS MC, CASTRO I, et al. Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS. Arq Neuropsiquiatr. 2017;75(8):515-522.
[24] 吴启超,张妍,张雯秀,等. 利鲁唑治疗脊髓损伤的研究进展[J]. 中国康复理论与实践,2018,24(6):650-653.
[25] OYINBO CA. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta neurobiologiae experimentalis. 2011;71(2):281-299.
[26] MORTEZAEE K, KHANLARKHANI N, BEYER C, et al. Inflammasome: Its role in traumatic brain and spinal cord injury. J Cell Physiol. 2018; 233(7):5160-5169.
[27] ABULAFIA DP, DE RIVERO VACCARI JP, LOZANO JD, et al. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab. 2009; 29(3):534-544.
[28] ADAMCZAK SE, DE RIVERO VACCARI JP, DALE G, et al. Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J Cereb Blood Flow Metab. 2014;34(4):621-629.
[29] TSUCHIYA K. Inflammasome-associated cell death: Pyroptosis, apoptosis, and physiological implications. Microbiol Immunol. 2020; 64(4):252-269.
[30] ZHOU Y, WEN LL, LI YF, et al. Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis. Neural Regen Res. 2022;17(1):194-202.
[31] LEHNARDT S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 2010;58(3):253-263.
[32] DAVID S, KRONER A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12(7):388-399.
[33] WALSH JG, MURUVE DA, POWER C. Inflammasomes in the CNS. Nat Rev Neurosci. 2014;15(2):84-97.
[34] ALBORNOZ EA, WOODRUFF TM, GORDON R. Inflammasomes in CNS Diseases. Exp Suppl. 2018;108:41-60.
|